Abstract:Introduction: Cardiac autonomic neuropathy (CAN) is a disorder affecting the autonomic nerves that regulate the cardiovascular system, leading to irregular heart rate and blood pressure control. It is commonly associated with diabetes mellitus but can also result from other conditions such as autoimmune disorders, chronic kidney disease, alcohol abuse, and certain medications. Screening for CAN is essential, particularly in individuals with poor glycemic control, cardiovascular risk factors, or complications. Early identification of CAN is vital for timely intervention to prevent or manage cardiovascular complications effectively. Regular screening helps detect CAN before symptoms emerge, enabling early intervention to slow or halt its progression. This study examined the relationship between sudomotor function and cardiovascular reflex tests. Material and methods: This was a cross-sectional study conducted between June 2019 and June 2020. The study included 271 subjects aged 18 years and above who provided informed consent, were diagnosed with type 2 diabetes mellitus (T2DM), and were overweight or obese. Exclusion criteria encompassed patients with other types of diabetes, pregnant women, those with recent neoplasm diagnoses, stroke sequelae, history of myocardial infarction, or pelvic limb amputations. The assessment of cardiac autonomic neuropathy involved conducting an electrocardiogram and evaluating the QTc interval in the morning before taking medication. Additionally, cardiovascular reflex tests (CART) were conducted, including assessments of heart rate variability during deep breathing, the Valsalva maneuver, and changes in orthostatic position. Simultaneously, the diagnosis of CAN was assessed by performing a sweat test using a Sudoscan assessment (Impeto Medical, Moulineaux, France). Results: More than half of the participants (52%, n=143) were female. Significant differences in statistical measures were noted between females and males regarding age, systolic blood pressure, fasting blood glucose, A1c level, total cholesterol, triglycerides, gamma-glutamyl transferase, and bilirubin levels. Within the CAN-diagnosed group (CAN+), 40.92% were classified as mild cases (n=90), 47.27% as moderate cases (n=104), and 11.81% as severe cases (n=26). Among the CAN+ group, 54% (n=119) were women. Electrochemical skin conductance was lower in the CAN+ group than the CAN- group in hands (67.34±15.51 μS versus 72.38±12.12 μS, p=0.008) and feet (73.37±13.38 μS versus 82.84 ±10.29 μS, p<0.001). The Sudoscan-CAN score significantly correlated with Ewing scores (r= 0.522, p<0.001). In multiple linear regression analysis, the Sudoscan-CAN score remained significantly associated with age, high BMI, long-standing diabetes, and Ewing score. Conclusions: Sudoscan demonstrates potential in identifying patients with an increased risk of CAN. Its integration into clinical practice can improve patient outcomes through early detection, risk stratification, and personalized treatment approaches. Its non-invasive, portable, and user-friendly features render it suitable for utilization in outreach programs or resource-constrained settings as part of screening efforts designed to pinpoint high-risk individuals for additional assessment.

Association of sudomotor dysfunction with risk of diabetic retinopathy in patients with type 2 diabetes

The Relationship Between β-cell Function Indices and Sudomotor Function in Chinese Patients with Type 2 Diabetes

Sudoscan is an Effective Screening Method for Asymptomatic Diabetic Neuropathy in Chinese Type 2 Diabetes Mellitus Patients

The Application of SUDOSCAN for Screening Diabetic Peripheral Neuropathy in Chinese Population Screening DPN by SUDOSCAN.

Self-Reported Depressive Symptoms Might Be Associated with Sudomotor Dysfunction in Chinese T2DM Patients

The value of SUDOSCAN in the early diagnosis and evaluation of diabetic microvascular complications

Correlation Between Glycemic Variability and Sudomotor Function in Patients with Type 2 Diabetes

Inverse Relationship Between Serum Cystatin C and Sudomotor Function Detected by SUDOSCAN in Chinese Patients With Type 2 Diabetes Mellitus

Electrochemical skin conductances values and clinical factors affecting sudomotor dysfunction in patients with prediabetes, type 1 diabetes, and type 2 diabetes: A single center experience

Screening and Prevalence of Peripheral Neuropathy in Type 2 Diabetic Outpatients: a Randomized Multicentre Survey in 12 City Hospitals of China

Continuous Glucose Monitoring Defined Time-in-range is Associated with Sudomotor Dysfunction in Type 2 Diabetes

Relationship Between Β-Cell Function and Sudomotor Function in Patients with Type 2 Diabetes Mellitus

Sudoscan as substitute for quantitative sudomotor axon reflex test in composite autonomic scoring scale and its correlation with composite autonomic symptom scale 31 in type 2 diabetes

Time in Range, Especially Overnight Time in Range, is Associated with Sudomotor Dysfunction in Patients with Type 1 Diabetes

Comprehensive assessment of ocular parameters for identifying diagnostic indicators of diabetic peripheral neuropathy

Sympathetic skin response for early detection of type 2 diabetic peripheral neuropathy and nephropathy

The Importance of Evaluating Sudomotor Function in the Diagnosis of Cardiac Autonomic Neuropathy

Analysis of retinal and choroidal characteristics in patients with early diabetic retinopathy using WSS-OCTA

Osteopontin and clusterin levels in type 2 diabetes mellitus: differential association with peripheral autonomic nerve function

Correlation Between Sweat Function and Cardiovascular Autonomic Neuropathy in Patients with Type 2 Diabetes